Evidence map›Paper›PMID 17928235›Full record

ReviewSeminars in cancer biology2008

Focal adhesion kinase as a regulator of cell tension in the progression of cancer.

Robert W Tilghman, J Thomas Parsons

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cancer biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Anoikis: To Die or Not to Die?International journal of molecular sciences · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. 3D TiACS nano · 2022
    Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robert W TilghmanDepartment of Microbiology, University of Virginia Health System, Charlottesville, VA 22908, USA.
J Thomas Parsons
University of Virginia Health System · US

Funding

STRUCTURE AND FUNCTION OF A CELLULAR TYROSINE PROTEIN KINASEP01CA040042 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MACARA, IAN G · 1985 to 2009
$10.5M
Function of Cortactin, a Src TargetR01CA029243 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PARSONS, J THOMAS · 1985 to 2005
$1.5M
FOCAL ADHESION KINASE SIGNALINGR01CA080606 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PARSONS, J THOMAS · 1999 to 2003
$239k
AVIAN TUMOR VIRUS ANTIGENSR37CA029243 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PARSONS, J THOMAS · 1992 to 1999
–
NCI NIH HHS CA 29243NCI NIH HHS CA 80606NCI NIH HHS P01 CA040042NCI NIH HHS R01 CA029243NCI NIH HHS R01 CA080606NCI NIH HHS R37 CA029243
6 · The paper itself

Abstract

Growing evidence indicates that critical steps in cancer progression such as cell adhesion, migration, and cell cycle progression are regulated by the composition and organization of the microenvironment. The adhesion of cancer cells to components of the microenvironment and the forces transmitted to the cells via the actinomyosin network and the signaling complexes organized within focal adhesions allow cancer cells to sense the local topography of the extracellular matrix and respond efficiently to proximal growth and migration promoting cues. Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase that is over expressed in a variety of cancers and plays an important role in cell adhesion, migration, and anchorage-dependent growth. In this review, we summarize evidence which implicate FAK in the ability of cells to sense and respond to local forces from the microenvironment through the regulation of adhesion dynamics and actinomyosin contractility, and we discuss the potential roles of FAK as a mechanosensor in the progression of cancer.

Indexed as

AnimalsAntineoplastic AgentsCell AdhesionCytoskeletal ProteinsDisease ProgressionEnzyme InhibitorsFocal Adhesion Protein-Tyrosine KinasesFocal AdhesionsHumansNeoplasmsSignal TransductionAntineoplastic AgentsCytoskeletal ProteinsEnzyme InhibitorsFocal Adhesion Protein-Tyrosine Kinases

Identifiers

PMID17928235
PMCPMC2267763
OpenAlexW1964006565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.